$3.61
0.102.85%
At close: -
$3.65
0.041.11%
After Hours: 7:58 PM EDT
Comments
Loading...
Iovance Biotherapeutics Stock Guidance | NASDAQ:IOVA | Benzinga
Iovance Biotherapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | IOVA | Iovance Biotherapeutics | FY | 2025 | — | — | — | $450.00M | $475.00M | $455.39M | Get Alert |
| 11/07/2024 | IOVA | Iovance Biotherapeutics | FY | 2025 | — | — | — | $450.00M | $475.00M | $461.26M | Get Alert |
| 11/07/2024 | IOVA | Iovance Biotherapeutics | FY | 2024 | — | — | — | $160.00M | $165.00M | $162.76M | Get Alert |
| 08/08/2024 | IOVA | Iovance Biotherapeutics | FY | 2025 | — | — | — | $450.00M | $475.00M | $403.71M | Get Alert |
| 08/08/2024 | IOVA | Iovance Biotherapeutics | FY | 2024 | — | — | — | $160.00M | $165.00M | $143.21M | Get Alert |
| 08/08/2024 | IOVA | Iovance Biotherapeutics | Q3 | 2024 | — | — | — | $53.00M | $55.00M | $49.04M | Get Alert |
FAQ
What is the most recent guidance for Iovance Biotherapeutics (IOVA)?
There have been no specific sales or earnings guidance reported for Iovance Biotherapeutics in recent months.
Browse guidance and forecast on all stocks.
